|Articles|May 27, 2016
Valeant Rejected Takeda Bid
May 27, 2016.
Advertisement
Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.
The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.
More on the story
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer
3
FDA Grants National Priority Voucher to Tecvayli Combination in Relapsed or Refractory Multiple Myeloma
4
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
5
